User profiles for Afschin Gandjour

Afschin Gandjour

Professor für Health Management, Frankfurt School of Finance & Management
Verified email at fs.de
Cited by 3359

Threshold volumes associated with higher survival in health care: a systematic review

A Gandjour, A Bannenberg, KW Lauterbach - Medical care, 2003 - journals.lww.com
Background. To date, systematic reviews on the relationship between the volume of specific
diagnoses and procedures and patient outcomes have several limitations, including the …

Mutual dependency between capabilities and functionings in Amartya Sen's capability approach

A Gandjour - Social Choice and Welfare, 2008 - Springer
Amartya Sen’s capability approach has recently been widely discussed as a theoretical
basis for making resource allocation decisions in health care. The purpose of this paper is to …

[HTML][HTML] Costs of patients with chronic kidney disease in Germany

A Gandjour, W Armsen, W Wehmeyer, J Multmeier… - PloS one, 2020 - journals.plos.org
Background This study aimed to determine the costs and distribution of healthcare spending
of patients with chronic kidney disease (CKD) at stages 3 and 4 and on dialysis both at the …

Nephron overload as a therapeutic target to maximize kidney lifespan

…, KR Tuttle, P Delanaye, H Liapis, A Gandjour… - Nature Reviews …, 2022 - nature.com
Kidney lifespan is a patient-oriented outcome that provides much needed context for
understanding chronic kidney disease (CKD). Nephron endowment, age-associated decline in …

Costs of dialysis—a regional population-based analysis

A Icks, B Haastert, A Gandjour… - Nephrology Dialysis …, 2010 - academic.oup.com
Background. Population-based estimates of costs of renal replacement therapy are scarce
in the literature. The aim of our study was to calculate the costs of long-term dialysis in 2006 …

[HTML][HTML] A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany

A Gandjour - Applied Health Economics and Health Policy, 2023 - Springer
Purpose Value-based pricing of new, innovative health technologies defined as pricing through
economic evaluation requires the use of a basic cost-effectiveness threshold. This study …

Does prevention save costs?: Considering deferral of the expensive last year of life

A Gandjour, KW Lauterbach - Journal of Health Economics, 2005 - Elsevier
Published cost-effectiveness analyses may overstate the cost-effectiveness ratio of preventive
care if they do not explicitly model the costs of the last year of life, which is postponed by …

Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results

M Dietlein, K Weber, A Gandjour, D Moka… - European journal of …, 2000 - Springer
Decision analysis is used here to establish the most cost-effective strategy for management
of potentially operable non-small cell lung cancers (NSCLCs). The strategies compared …

The clinical and economic value of a successful shutdown during the SARS-CoV-2 pandemic in Germany

A Gandjour - The Quarterly Review of Economics and Finance, 2022 - Elsevier
Background and aim A shutdown of businesses enacted during the SARS-CoV-2 pandemic
can serve different goals, eg, preventing the intensive care unit (ICU) capacity from being …

[HTML][HTML] Predictors of negotiated prices for new drugs in Germany

A Gandjour, S Schüßler, T Hammerschmidt… - The European Journal of …, 2020 - Springer
Introduction In Germany, all new, innovative medicines are subject to an early benefit
assessment by the German Federal Joint Committee with subsequent price negotiation and …